Chemomab Therapeutics (2QV) Stock Forecast & Price Target
2QV Analyst Ratings
There are no analyst ratings in the last 3 months.
2QV Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Michael Okunewitch | Maxim Group | EUR 4.46 | buy | 51.77%Upside | Reiterated | 07/13/26 | ||
| Jeff Jones | Oppenheimer | EUR 22.31 | buy | 658.85%Upside | Reiterated | 05/15/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Michael OkunewitchMaxim Group | BuyReiteratedEUR 4.46 | 07/13/26 | 51.77%Upside | ||
| Jeff JonesOppenheimer | BuyReiteratedEUR 22.31 | 05/15/26 | 658.85%Upside |
Best Analysts Covering Chemomab Therapeutics
Copying Michael Okunewitch's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +4.47% per trade.
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -28.12% per trade.
Copying Jeff Jones's trades and holding each position for 2 Years would result in 6.25% of your transactions generating a profit, with an average return of -63.04% per trade.
2QV Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 3 | 1 | 1 | 0 | 0 |
In the current month, 2QV has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2QV average Analyst price target in the past 3 months is ―.
2QV Financial Forecast
2QV Earnings Forecast
Next quarter’s earnings estimate for 2QV is EUR 0.00 with a range of EUR 0.00 to EUR 0.00. The previous quarter’s EPS was EUR 0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
2QV Sales Forecast
Next quarter’s sales forecast for 2QV is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
